Mumbai, Feb. 24 -- SteinCares, a leading specialty healthcare company in Latin America, and Shilpa Biologicals, a fully integrated biopharmaceutical company and subsidiary of Shilpa Medicare, announce a strategic licensing agreement to commercialize a biosimilar across Latin America.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.